Reversible cerebral vasoconstriction syndrome (RCVS) is characterized by an acute onset of severe headache and multi-focal segmental vasoconstriction of cerebral arteries resolving within 12 weeks. Diagnostic criteria include normal or near-normal findings in cerebrospinal fluid (CSF) analysis, especially leucocyte levels < 10/mm 3 . Distinguishing RCVS from primary angiitis of the central nervous system (PACNS) is essential to avoid unnecessary and sometimes unfavourable immunosuppressive treatment. We reviewed retrospectively the clinical and diagnostic data of 10 RCVS patients who presented in our neurological department from 1 January 2013 to February 2017. The main purpose was to verify whether CSF leucocyte counts < 10/ mm 3 serve to discriminate RCVS from PACNS. Five of six patients who underwent lumbar puncture presented with CSF leucocyte levels ! 10/mm 3 . Two patients had a history of misinterpretation of CSF pleocytosis as cerebral vasculitis and of immunosuppressive treatment. A complete restitution of cerebral vasoconstriction was evident in all. No patient had further cerebral strokes or bleedings without immunosuppressive treatment over more than 12 weeks. Despite the established diagnostic criteria, RCVS can manifest with CSF leucocyte levels > 10/mm 3 . Careful anamnesis and the response of 'vasculitis-like angiography' to nimodipine given as a test during angiography and as oral medication are key to differentiate RCVS from cerebral vasculitis.
Summary
Reversible cerebral vasoconstriction syndrome (RCVS) is characterized by an acute onset of severe headache and multi-focal segmental vasoconstriction of cerebral arteries resolving within 12 weeks. Diagnostic criteria include normal or near-normal findings in cerebrospinal fluid (CSF) analysis, especially leucocyte levels < 10/mm 3 . Distinguishing RCVS from primary angiitis of the central nervous system (PACNS) is essential to avoid unnecessary and sometimes unfavourable immunosuppressive treatment. We reviewed retrospectively the clinical and diagnostic data of 10 RCVS patients who presented in our neurological department from 1 January 2013 to February 2017. The main purpose was to verify whether CSF leucocyte counts < 10/ mm 3 serve to discriminate RCVS from PACNS. Five of six patients who underwent lumbar puncture presented with CSF leucocyte levels ! 10/mm 3 . Two patients had a history of misinterpretation of CSF pleocytosis as cerebral vasculitis and of immunosuppressive treatment. A complete restitution of cerebral vasoconstriction was evident in all. No patient had further cerebral strokes or bleedings without immunosuppressive treatment over more than 12 weeks. Despite the established diagnostic criteria, RCVS can manifest with CSF leucocyte levels > 10/mm Introduction Reversible cerebral vasoconstriction syndrome (RCVS) is a cerebral angiopathy whose main features are acute onset of severe 'thunderclap' headache and multi-focal segmental cerebral artery vasoconstriction. There is a high risk for stroke and cortical subarachnoid haemorrhage. The diagnostic criteria include reversibility of angiographic abnormalities within 12 weeks and normal or near-normal findings on cerebrospinal fluid (CSF) analysis, especially normal glucose levels, protein levels < 80mg/dl and leucocyte counts < 10/mm 3 [1] (Tables 1 and 2) . Traditionally, CSF analysis is thought to be essential to distinguish RCVS from primary angiitis of the central nervous system (PACNS) to avoid initiation of unnecessary immunosuppressive treatment and inappropriate and ineffective treatment with nimodipine [2] . The differential diagnosis is often challenging, sometimes leading to brain biopsies in the workup to achieve diagnostic certainty [3] .
In this context, we analysed retrospectively whether an elevated CSF cell count of ! 10/mm 3 according to the diagnostic criteria confidently allows exclusion of RCVS.
Material and methods
Patients were examined at the Department of Neurology of the Alfried Krupp-Hospital in Essen (Germany). We reviewed retrospectively the case records of 115 patients from 1 January 2013 to February 2017 who were encoded as 'Other cerebrovascular diseases' , according to ICD-10. Twelve patients matched the criteria of acute thunderclap headache and/or multi-focal reversible abnormalities on catheter, computerized tomography (CT) or magnetic resonance imaging (MRI) angiography and transcranial ultrasound without the evidence for cerebral vasculitis. One patient was excluded because her headache was interpreted as associated with a viral infection. One patient was excluded because the diagnostic workup revealed a persistent stenosis of her cerebral arteries and 
Results
Ten patients were diagnosed as RCVS (six females, four males, mean age 5 43Á2 years). All showed multi-focal vasoconstriction (in duplex ultrasound, magnetic resonance angiography or conventional angiography). Eight of the 10 patients reported severe headache; only one patient was classified as headache intensity 7 on the NRS. One patient presented with reduced vigilance, so anamnestic data could not be evaluated. Seven of 10 patients were considered to be exposed to RCVS, provoking triggers such as postpartal status (two patients) and vasoactive medication or drugs such as fluoxetine, tiotropium bromide or consumption of cannabis. In one patient RCVS occurred in the context of medication with fingolimod, which has been incriminated as a provoking factor elsewhere [4] . Strokes were detected in nine of 10 patients; one patient showed cortical subarachnoid haemorrhage in two locations. Six of 10 patients underwent lumbar puncture in the acute phase of symptom presentation. In five of these six patients the CSF leucocyte counts were ! 10/mm 3 (10/ . Oligoclonal bands were positive in two patients; one of these had a comorbid multiple sclerosis [4] . Cytological analysis revealed a lymphomonocytic pleocytosis in four cases and granulocytes and lymphocytes in one patient. One patient with leucocyte counts of 23/mm Early puerperium, late pregnancy, eclampsia, pre-eclampsia and delayed postpartum eclampsia Medication, drugs and blood products Phenylpropanolamine, pseudoephedrine, ergotamine tartrate, methergine, nicotine patches, bromocryptine, lisuride, selective serotonin reuptake inhibitors, sumatriptan, isometheptine, cocaine, ecstasy, amphetamine derivatives, marijuana, lysergic acid diethylamide, tacrolimus (FK-506), atovaquone, fingolimod, isoflavones, irreversible, non-selective monoamine oxidase (MAO) inhibitors cyclophosphamide, erythropoetin, intravenous immune globulin and red blood cell transfusions Other triggering factors Hypomagnemia, hypercalcaemia, porphyria, catecholamine-secreting tumours such as pheochromocytoma and bronchial carcinoid tumour, head trauma, spinal subdural haematoma, post-carotid endarterectomy and neurosurgical procedures Associated conditions No identifiable precipitating factor Associated with headache disorders, such as migraine, primary thunderclap headache, benign exertional headache, benign sexual headache and primary cough headache Associated with posterior reversible encephalopathy syndrome cervical artery dissections, unruptured saccular cerebral aneurysma, cerebral arterial dysplasia Table 3 . 
Discussion
Distinguishing reversible cerebral vasoconstriction syndrome from PACNS is essential in young patients presenting with headaches and/or neurological deficits when angiography reveals stenosis of the intracranial arteries [5] (Table 4) . Catheter angiography itself often fails to distinguish these two entities reliably during the acute course of the disease, while CSF analysis is thought to be of high diagnostic importance, especially as established diagnostic criteria include a threshold of < 10/mm 3 CSF leucocytes [1] .
However, in some cases the course of disease is typical for RCVS despite higher leucocyte counts. We therefore decided to analyse if a CSF cell count of ! 10/mm 3 consequently allows exclusion of RCVS or if the diagnosis can also be posed in patients with higher CSF cell counts. We reviewed a cohort of 10 patients fulfilling the diagnostic criteria of RCVS with complete relief of symptoms and angiographic pathology within 12 weeks. Concerning the rate of triggered vasculopathies, our cohort is concordant with approximately two-thirds of patients in former literature [6] . Moreover, demographic data, clinical presentation and angiographic signs were comparable with the literature. However, in contrast to other reports, migraine was not a frequent comorbidity in our patients [7] .
In five of six patients with the diagnosis of RCVS who underwent lumbar puncture the CSF analysis revealed leucocyte levels ! 10/mm 3 . According to the diagnostic criteria this finding should have led to exclusion of the diagnosis. Nevertheless, the diagnostic workup showed a complete restitution of cerebral artery vasoconstriction within 4 weeks to 3 months which could be excluded to appear in PACNS without immunosuppressive therapy. Other case-series examining more patients than ours also included patients with cell counts > 10/mm 3 , with rates of 3% or almost 10% [6, 8] . However, a conclusive interpretation is lacking in the literature, as well as the discussion of whether the diagnostic criterion of CSF leucocyte counts < 10/mm 3 should be maintained. Singhal et al. [6] concluded that CSF abnormalities may be associated with the co-existence of stroke. Rates of stroke in RCVS patients range at approximately 40% [6, 8] . Generally, watershed infarction and/or vasogenic oedema are thought to be classical MRI findings in RCVS. Currently, there are no data available of whether the localization of infarction, co-existence of vasogenic oedema or the time-course, i.e. the time CSF analysis takes place, have impacts upon leucocyte counts. [2, 10] . Enhancement on vessel wall imaging is not specific for cerebral vasculitis [11] . It is crucial to consider that the character of headaches is stronger and occurs more abruptly ('thunderclap') in RCVS than in vasculitis [2, 10] . Singhal et al. [3] suggested a bedside test based on the anamnestic data of thunderclap headache with a 100% positive predictive value for RCVS. Recently, intra-arterial infusion of nimodipine was shown to be a helpful differential diagnostic tool in selected patients with suspected RCVS [12] . This results in a normalization of both the diameter of the main trunks of the cerebral vessels and the calibre of the peripheral vessels quickly after intra-arterial nimodipine in RCVS [12] . According to the data presented, we recommend the intra-arterial nimodipine test or oral nimodipine treatment and watchful waiting over 12 weeks as a safe option in patients with thunderclap headaches, and angiography with suspected vasculitis and CSF pleocytosis [2] . We also recommend not to rule out RCVS in patients with CSF leucocyte levels ! 10/mm 3 and to keep in mind that this could be a more frequent pitfall than presumed previously [2, 5] .
Clinical implications
Headache is an important presenting symptom of RCVS and cerebral vasculitis CSF can fail to differentiate between these two entities
